Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells
Tianzhi Huang, Yongyong Yang, Xiao Song, et al.
Molecular Cell (2021) Vol. 81, Iss. 6, pp. 1276-1291.e9
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Amino acid metabolism in health and disease
Zhenan Ling, Yifan Jiang, Jun-Nan Ru, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 201
Principles of nucleosome recognition by chromatin factors and enzymes
Robert K. McGinty, Song Tan
Current Opinion in Structural Biology (2021) Vol. 71, pp. 16-26
Open Access | Times Cited: 111
A mycobacterial effector promotes ferroptosis-dependent pathogenicity and dissemination
Lihua Qiang, Yong Zhang, Zehui Lei, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 60
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
Yunxing Shi, Yi Niu, Yichuan Yuan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 21
The Emerging Role of PRMT6 in Cancer
Zhixian Chen, Jianfeng Gan, Zhi Wei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 47
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
Frank Eckerdt, Leonidas C. Platanias
Cancers (2023) Vol. 15, Iss. 13, pp. 3458-3458
Open Access | Times Cited: 36
Using mass spectrometry imaging to map fluxes quantitatively in the tumor ecosystem
Michaela Schwaiger-Haber, Ethan Stancliffe, Dhanalakshmi S. Anbukumar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
Ming Jin, Kwang Won Jeong
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1333-1347
Open Access | Times Cited: 32
Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
Qing Li, Liren Zhang, Qin Yang, et al.
Cell Metabolism (2023) Vol. 35, Iss. 6, pp. 912-927.e7
Open Access | Times Cited: 30
PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer
Qianzhi Chen, Qingyi Hu, Yan Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 26
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 25
circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation
Xinyu Yang, Jinting Liu, Wancheng Liu, et al.
Leukemia (2024) Vol. 38, Iss. 5, pp. 1057-1071
Closed Access | Times Cited: 9
PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism
Mingming Sun, Leilei Li, Yujia Niu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 1, pp. 157-173
Open Access | Times Cited: 36
PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism
Yunfei Liao, Zaili Luo, Yifeng Lin, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 35
Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks
Lea Stitzlein, Jack T. Adams, Erin N. Stitzlein, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
PRMT1 in human neoplasm: cancer biology and potential therapeutic target
Shiquan Shen, Honglong Zhou, Zongyu Xiao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING
Erliang Kong, Hua Tong, Jian Li, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2552-2565
Open Access | Times Cited: 7
PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt–β-catenin pathway
Peng Yu, Tutu Xu, Wenmeng Ma, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
MAPP unravels frequent co-regulation of splicing and polyadenylation by RNA-binding proteins and their dysregulation in cancer
Maciej Bąk, Erik van Nimwegen, Ivan U. Kouzel, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
The PRMT6/STAT1/ACSL1 axis promotes ferroptosis in diabetic nephropathy
Jia Hong, Xue Li, Yingxiang Hao, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 11, pp. 1561-1575
Closed Access | Times Cited: 7
The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
Qiong Wu, Anders Berglund, Arnold B. Etame
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8324-8324
Open Access | Times Cited: 35
PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B
Ji Wang, Zongyu Xiao, Peng Li, et al.
Oncogene (2023) Vol. 42, Iss. 14, pp. 1088-1100
Open Access | Times Cited: 16
The PRMT6/PARP1/CRL4B Complex Regulates the Circadian Clock and Promotes Breast Tumorigenesis
Tianshu Yang, Wei Huang, Tianyu Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 15
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)
Kailiang Wu, Chen Niu, Hanjiao Liu, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 5
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top